Device assistants are turning into orchestrators, going beyond answering questions to taking actions. For journalism, that ...
We're getting better networking and cleaner code in this stable release.
Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...